Hepatic organelle interaction. 3. Mitochondrial modification of microsomal drug metabolism.
D000633:Aminopyrine N-Demethylase; D000814:Aniline Compounds; D000818:Animals; D002952:Citric Acid Cycle; D003486:Cyanides / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System; D003579:Cytochrome Reductases; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000201:enzymology; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000201:enzymology; D008297:Male; D008854:Microscopy, Electron; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008930:Mitochondria, Liver; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009019:Morphinans; D009247:NADH, NADPH Oxidoreductases; D009249:NADP / Q000494:pharmacology; D010071:Oxaloacetates / Q000494:pharmacology; D010089:Oxidoreductases, N-Demethylating; D010101:Oxygen Consumption; D051381:Rats; D013386:Succinates / Q000494:pharmacology
D000814:Aniline Compounds; D003486:Cyanides; D009019:Morphinans; D010071:Oxaloacetates; D013386:Succinates; D009249:NADP; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; D010089:Oxidoreductases, N-Demethylating; D000633:Aminopyrine N-Demethylase; D009247:NADH, NADPH Oxidoreductases; D003579:Cytochrome Reductases